Daptomycin

NDC 67184-0549 · Qilu Pharmaceutical Co., Ltd.

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength500 mg/10mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryANDA

Packages

67184-0549-1 — 1 VIAL, SINGLE-USE in 1 CARTON (67184-0549-1) / 10 mL in 1 VIAL, SINGLE-USE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-179 — Daptomycin, 31722-215 — Daptomycin, 31722-216 — Daptomycin, 42023-295 — Daptomycin, 43598-413 — Daptomycin, 43598-476 — Daptomycin, 55150-344 — DAPTOMYCIN, 60505-6229 — Daptomycin, 60977-145 — daptomycin, 63323-371 — Daptomycin, 67457-813 — daptomycin, 67457-941 — daptomycin, 68001-376 — Daptomycin, 70377-093 — Daptomycin, 70436-033 — daptomycin, 70511-182 — Daptomycin, 70594-034 — Daptomycin, 70594-053 — Daptomycin, 70594-060 — daptomycin, 70594-066 — daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources